1. Afonso, L.C.C., Scharton, T.M., Vieira, L.Q., Wysocka, M., Trinchieri, G., and Scott, P., 1994, The adjuvant effect of interleukin-12 in a vaccine against Leishmania major, Science 263: 235–237.
2. Beyer, W.E.P., Palache, A.M., B alj et, M., and Masurel, N., 1989, Antibody induction by influenza vaccines in the elderly: a review of the literature, Vaccine 7: 385–394.
3. Brey, R.N. 1995. “Development of vaccines based on formulations containing nonionic block copolymers.” In Vaccine Design, M. F. Powell and M. J. Newman ed. Plenum Press. New York.
4. Butterly, L., Watkins, E., and Dienstag, J.L., 1989, Recombinant-yeast derived hepatitis B vaccine in healthy adults: safety and two-year immunogenicity of early investigative lots of vaccine, J. Med. Viral. 27: 155–159.
5. Byars, N.E., Allison, A.C., Harmon, M.W., and Kendal, A.P., 1990, Enhancement of antibody responses to influenza B virus haemagglutinin by use of a new adjuvant formulation, Vaccine 8: 49–56.